Senior insider sale
Chief Commercial Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$15.2K
29.16K shares
What this filing means
BALDRY MARK plans to sell 29.16K shares of X4 PHARMACEUTICALS, INC valued at approximately $15.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/24/2025ACC: 0001973141-25-000037
Officer· Chief Commercial Officer
Since Nov 2022
29.16K
Shares to sell
$15.2K
Approx. market value
29.16K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Award
N/A
1/23/2025
29.16KTotal acquired29.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | Stock Award N/A | 29.16K | — |
| Total | 29.16K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
29.16K
Market value
$15.2K
1/24/2025
Total
Units
29.16K
Value
$15.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/24/2025 | 29.16K | $15.2K | NASDAQ | Planned |
| Total | 29.16K | $15.2K | ||